How Long Between Allergy Shots? Scheduling Intervals and Missed-Dose Rules

The consequences of waiting too long between allergy shots depend on how long the gap is and which phase of treatment you are in. During build-up, a gap of 2-3 weeks requires repeating the last dose; 3-4 weeks requires reducing by 1 dose; 4-5 weeks requires reducing by 2 doses; gaps of 90 days or more during build-up typically require restarting from the first vial. During maintenance, gaps up to 5 weeks can continue at the same dose; 5-7 weeks requires a 25% reduction; 7-11 weeks about 45% reduction; 8-15 weeks about 55% reduction; and gaps of 3-4 months or more in maintenance typically require restarting from the beginning (Larenas-Linnemann et al., Ann Allergy Asthma Immunol 2020). These reductions are safety precautions — waning immune adaptation means the previous dose may now trigger a systemic reaction.

Yes — some protocols support extending the maintenance interval from 4 to 6 weeks after patients have been stable on maintenance for at least 1-2 years, and some evidence supports up to 8 weeks without significant efficacy loss. Tinkelman and Avner (JACI 1990) demonstrated comparable outcomes with extended 6-week maintenance intervals in a controlled trial. The AAAAI/ACAAI Practice Parameter (Cox 2011) acknowledges extended intervals as acceptable in clinically stable patients, noting that many practices individualize the schedule based on patient response and travel logistics. Extension to 6-8 weeks is not the same as stopping treatment — it reduces visit burden while maintaining adequate allergen exposure to sustain IgG4 levels and immune tolerance.

Cluster immunotherapy compresses the build-up phase by administering 2-3 progressively higher doses on a single day, repeated 1-2 times per week, until maintenance is reached. This achieves maintenance in approximately 4-8 weeks instead of 4-6 months with conventional weekly build-up, requiring roughly 50% fewer total visits (Calabria, Ann Allergy Asthma Immunol 2023). The per-injection systemic reaction rate is approximately 3 times higher with cluster than conventional build-up (Chen et al., Ann Allergy 2023), though per-patient reaction rates are statistically comparable when patient selection criteria are followed. Cluster protocols are appropriate for patients with stable asthma (FEV1 above 70%), no history of severe systemic reactions, and access to facilities where immediate epinephrine and monitoring are available.

Many allergists recommend holding the allergy shot dose constant or slightly reducing it during peak pollen season for the patient's relevant allergen. Larenas-Linnemann et al. (Ann Allergy Asthma Immunol 2012) found 40% of US allergists reduce doses during pollen season. The rationale is that patients experiencing active allergic responses have heightened immune sensitivity that increases systemic reaction risk during that season. Lockey et al. (JACI 1987) found 41% of historical SCIT-related deaths occurred during patients' pollen seasons. Some allergists maintain the full maintenance dose year-round without problems, particularly if the patient has been stable for multiple seasons. Your allergist will advise based on your symptom patterns and reaction history.

Yes — allergy shots can typically be transferred between allergist offices when moving, but the process requires proper extract documentation and often involves a dose reduction on the first visit at the new practice. The new allergist needs the exact extract formulation, concentrations, and most recent dose history to determine the appropriate starting dose at their office. Gaps during the transfer process — while finding a new provider, coordinating documentation, and scheduling the first appointment — must be accounted for using the standard missed-interval dose adjustment protocols. Gaps exceeding 8 weeks during maintenance at the old practice before starting at the new practice may require a partial or full restart. Planning transfers proactively and requesting documentation before your last appointment at the old practice minimizes this disruption.

In standard protocols, only one injection is given per visit. When cluster protocols administer multiple doses per visit, shots within a visit are typically separated by 20-30 minutes of observation between each dose. Rush protocols may space injections as closely as every 15 minutes under continuous medical monitoring with IV access and emergency equipment available. The 30-minute observation period after the final injection of any visit applies regardless of protocol. In conventional practice, giving two separate allergy shot doses on the same calendar day at different times is not standard protocol and would not be done without specific medical rationale, as the cumulative allergen load from same-day dosing increases systemic reaction risk.